[go: up one dir, main page]

IS6992A - Meðhöndlun á ADHD - Google Patents

Meðhöndlun á ADHD

Info

Publication number
IS6992A
IS6992A IS6992A IS6992A IS6992A IS 6992 A IS6992 A IS 6992A IS 6992 A IS6992 A IS 6992A IS 6992 A IS6992 A IS 6992A IS 6992 A IS6992 A IS 6992A
Authority
IS
Iceland
Prior art keywords
adhd
treatment
Prior art date
Application number
IS6992A
Other languages
English (en)
Inventor
Peter Hertel Klaus
Arnt Jørn
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of IS6992A publication Critical patent/IS6992A/is

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Recrystallisation Techniques (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Indole Compounds (AREA)
IS6992A 2001-05-09 2003-10-13 Meðhöndlun á ADHD IS6992A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200100732 2001-05-09
PCT/DK2002/000298 WO2002089797A1 (en) 2001-05-09 2002-05-07 Treatment of adhd

Publications (1)

Publication Number Publication Date
IS6992A true IS6992A (is) 2003-10-13

Family

ID=8160484

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6992A IS6992A (is) 2001-05-09 2003-10-13 Meðhöndlun á ADHD

Country Status (23)

Country Link
US (1) US7294638B2 (is)
EP (1) EP1387682A1 (is)
JP (1) JP2004528361A (is)
KR (1) KR20040007544A (is)
CN (1) CN1507351A (is)
AR (1) AR033287A1 (is)
BG (1) BG108400A (is)
BR (1) BR0209443A (is)
CA (1) CA2446652A1 (is)
CO (1) CO5540378A2 (is)
CZ (1) CZ20033197A3 (is)
EA (1) EA200301221A1 (is)
HR (1) HRP20030852A2 (is)
HU (1) HUP0400075A2 (is)
IL (1) IL158413A0 (is)
IS (1) IS6992A (is)
MX (1) MXPA03010136A (is)
NO (1) NO20034972L (is)
NZ (1) NZ528896A (is)
PL (1) PL367778A1 (is)
SK (1) SK15002003A3 (is)
WO (1) WO2002089797A1 (is)
ZA (1) ZA200307955B (is)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003102097A1 (en) * 2002-05-31 2003-12-11 H. Lundbeck A/S The hydrochloride of (s)-(+)-3-[1-[2-(1-acetyl-2,3-dihydro-1h-indol-3-yl)ethyl]-1,2,3,6-tetrahydropyridin-4-yl]-6-chloro-1h-indole
EP1812390A2 (en) * 2004-10-22 2007-08-01 Mark Froimowitz Methylphenidate analogs and methods of use thereof
EP2288362A4 (en) * 2008-04-19 2012-05-02 Nisarga Biotech Pvt Ltd PLANT-BASED COMPOSITION FOR DECREASING ADD / L ADHD, AND METHOD THEREOF

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5521197A (en) * 1994-12-01 1996-05-28 Eli Lilly And Company 3-<1-alkylenearyl>-4-<1,2,3,6-tetrahydropyridinyl>-and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-HT1F agonists
ZA9711376B (en) * 1996-12-20 1998-07-21 Lundbeck & Co As H Indole or dihydroindole derivatives
WO2002046156A2 (en) * 2000-12-06 2002-06-13 Sepracor, Inc. 4,4-disubstituted piperidines for use as dopamine, serotonin and norepinephrine ligands

Also Published As

Publication number Publication date
EA200301221A1 (ru) 2004-04-29
PL367778A1 (en) 2005-03-07
IL158413A0 (en) 2004-05-12
NZ528896A (en) 2004-12-24
JP2004528361A (ja) 2004-09-16
KR20040007544A (ko) 2004-01-24
CA2446652A1 (en) 2002-11-14
MXPA03010136A (es) 2004-03-10
NO20034972D0 (no) 2003-11-07
BR0209443A (pt) 2004-08-03
CO5540378A2 (es) 2005-07-29
EP1387682A1 (en) 2004-02-11
US7294638B2 (en) 2007-11-13
NO20034972L (no) 2003-11-07
WO2002089797A8 (en) 2004-03-25
BG108400A (bg) 2004-11-30
HUP0400075A2 (hu) 2004-04-28
US20040152737A1 (en) 2004-08-05
ZA200307955B (en) 2004-10-13
SK15002003A3 (sk) 2004-05-04
WO2002089797A1 (en) 2002-11-14
AR033287A1 (es) 2003-12-10
HRP20030852A2 (en) 2005-06-30
CZ20033197A3 (en) 2004-06-16
CN1507351A (zh) 2004-06-23

Similar Documents

Publication Publication Date Title
NO20035156L (no) Fremgangsmåter for brønnbehandling
EP1288654A4 (en) BIOSENSOR
EP1318396A4 (en) BIOSENSOR
EP1308720A4 (en) BIOSENSOR
EP1398626A4 (en) Biosensor
EP1445605A4 (en) BIOSENSOR
EP1353169A4 (en) BIOSENSOR
KR100695846B9 (ko) 암 치료
EP1281955A4 (en) BIOSENSOR
DK1342881T3 (da) Opskummet syrebehandlingsvæske
DE50208638D1 (de) Katheter
EP1446129A4 (en) POLYNUCLEOTIDE THERAPY
DE60226578D1 (de) Chirurgische greifvorrichtung
DE60217317D1 (de) Wärmebehandlungsverfahren
IS7137A (is) Samsett meðferð til meðhöndlunar á krabbameini
IS6954A (is) Notkun á enantíómerískt hreinu essítalóprami
EP1452856A4 (en) BIOSENSOR
DE60200578D1 (de) Ozonsterilisationsverfahren
DE60236743D1 (de) Zur behandlung androgenabhängiger krankheiten
IS7163A (is) Aðferðir til meðhöndlunar á lungnasjúkdómi
DE60227963D1 (de) Behandlungssystem
DE60220220D1 (de) Blutbehandlungssystem
IS3004B (is) Aðferð til meðhöndlunar á svefnleysi á frumstigi
SE0301854L (sv) Antiigensättningsbehandling
DE60114244D1 (de) Osteosynthesevorrichtung